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Introduction {#sec001}
============

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver biochemistry worldwide. The prevalence of NAFLD is increasing in Asia. The prevalence of NAFLD across Asia varies from 5% to 40% \[[@pone.0122406.ref001], [@pone.0122406.ref002]\] NAFLD may progress to nonalcoholic steatohepatitis (NASH), cirrhosis, liver failure and liver cancer, and is believed to be the leading etiology for cryptogenic cirrhosis \[[@pone.0122406.ref003], [@pone.0122406.ref004]\]. NAFLD is also strongly associated with obesity and metabolic syndrome, and is shown to be an independent cardiovascular risk factor \[[@pone.0122406.ref005], [@pone.0122406.ref006]\]. Therefore, there is growing interest in determining risk factors for hepatic steatosis.

Hormonal changes have been linked to the development and severity of NAFLD. There is growing evidence to suggest that reduced levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) in adults is associated with an increased prevalence of NAFLD and progression to NASH or liver cirrhosis \[[@pone.0122406.ref007]--[@pone.0122406.ref009]\]. Meanwhile, substantial evidence from animal studies and human studies shows that metabolic acidosis suppresses GH secretion and IGF-I response \[[@pone.0122406.ref010], [@pone.0122406.ref011]\]. Diet composition can influence the acid-base balance \[[@pone.0122406.ref012]\]. Although diet-induced 'low-grade' metabolic acidosis has minimal adverse effects in short-term, a prolonged diet-induced high acid load may lead to a mild form of chronic metabolic acidosis and is considered to have significant clinical relevance \[[@pone.0122406.ref013]\]. Since NAFLD and metabolic acidosis are both associated with reduced levels of GH and IGF-I, it is possible to speculate that diet-induced acid load may constitute a nutritional factor with influence on NAFLD development.

To our knowledge, the association between diet-induced acid load and NAFLD risk has been rarely reported. Only one study has examined such association in a group of healthy Caucasian young men and women, and showed that higher dietary acidity in adolescence may be prospectively associated with hepatic lipid accumulation in females \[[@pone.0122406.ref014]\]. Although the study was prospective in nature, it had several methodological limitations including small sample size, selective sample, and use of alanine aminotransferase (ALT), hepatic steatosis index (HSI), and fatty liver index (FLI) as surrogates of NAFLD.

In view of the above limitations, the scarcity of evidence on this topic as well as the fact that Chinese diets are different from Western diets, the present study aimed to explore the association of dietary acid-base load with NAFLD prevalence in 793 Chinese aged 19--72 years, using data from a population-based study in Hong Kong. We speculated that higher dietary acid-base load was associated with an increased likelihood of NAFLD as measured using proton-magnetic resonance spectroscopy. Since NAFLD is benign in most of the cases, we also explored the association between dietary acid-base load and the likelihood of advanced fibrosis as measured using transient elastography.

Materials and Methods {#sec002}
=====================

Study population {#sec003}
----------------

This was a cross-sectional population-based study. The study population included 793 subjects who participated in a population screening for NAFLD. Details of the screening project have been reported previously \[[@pone.0122406.ref015], [@pone.0122406.ref016]\]. In brief, 1,069 subjects aged 18 to 72 years and randomly selected from the government census database agreed to participate in the screening project from May 2008 to September 2010. Those with active malignancy, metallic implants or other contraindications to magnetic resonance imaging, positive hepatitis B surface antigen or antibody against hepatitis C virus, secondary causes of fatty liver (e.g. consumption of amiodarone and tamoxifen) and decompensated liver disease (defined as bilirubin above 50 μmol/l, albumin below 35 g/l, platelet count below 150 × 10^9^/l, international normalized ratio above 1.3, or the presence of ascites or varices) (n = 147), with excessive alcohol use (defined as more than 20 g/d day in men and more than 10 g/d in women) (n = 30), with incomplete dietary data (n = 95), and without body mass index (BMI) data (n = 4) were excluded from the final analysis. The study protocol conformed to the ethical guidelines of the Declaration of Helsinki, and was approved by the Clinical Research Ethics Committee of The Chinese University of Hong Kong. All subjects provided informed written consent.

Clinical assessment {#sec004}
-------------------

At the baseline clinic visit, drug history, alcohol intake, smoking and past medical history were recorded using a standardized questionnaire. Alcohol consumption of 20 g daily (140 g weekly) for men and 10 g daily (70 g weekly) for women was the threshold to define NAFLD \[[@pone.0122406.ref017]\]. Anthropometric measurements including body weight, body height, waist and hip circumferences were obtained using standardized methods. BMI was calculated as weight (kg) divided by height (m) squared. Waist circumference (WC) was measured at a level midway between the lower rib margin and iliac crest with the tape all around the body in the horizontal position. Hip circumference (HC) was measured as the maximum circumference around the buttocks posteriorly and the symphysis pubis anteriorly. Waist-to-hip ratio (WHR) was calculated as the waist divided by the hip circumference.

Blood tests for liver biochemistry, glucose and lipids were taken after at least 8 hours of fasting. Metabolic syndrome was defined according to the ethnic-specific criteria by the International Diabetes Federation, which was modified from the National Cholesterol Education Program, Adult Treatment Panel III Guidelines, as any three of the followings: (i) waist circumference ≥90 cm in men and ≥80 cm in women; (ii) triglycerides \>1.7 mmol/L; (iii) high-density lipoprotein-cholesterol \<1.03 mmol/L in men and \<1.29 mmol/L in women; (iv) blood pressure ≥130/85 mmHg; and (v) fasting plasma glucose ≥5.6 mmol/L; or receiving treatment for the above metabolic abnormalities \[[@pone.0122406.ref018]\].

Proton-magnetic resonance spectroscopy (^1^H-MRS) {#sec005}
-------------------------------------------------

^1^H-MRS was performed to measure intrahepatic triglyceride content (IHTG) within 8 weeks from the baseline visit. Details of the scanning sequence and analysis have been described previously \[[@pone.0122406.ref015], [@pone.0122406.ref019]\]. Whole-body 3.0T scanner with a single voxel point-resolved spectroscopy sequence and an echo time of 40 ms and repetition time of 5,000 ms was used. Fatty liver was defined as an IHTG of 5% or more \[[@pone.0122406.ref020]\].

Transient elastography {#sec006}
----------------------

Liver stiffness measurement by transient elastography (Fibroscan, Echosens, Paris, France) was performed at the baseline clinic visit according to the instructions and training provided by the manufacturer. Ten successful acquisitions were performed on each subject. The success rate was calculated as the ratio of the number of successful acquisitions over the total number of acquisitions. The median value represented the liver elastic modulus. Liver stiffness measurements were considered reliable only if 10 successful acquisitions were obtained, the success rate was \>60% and the interquartile range to median ratio of the 10 acquisitions was \<0.3. Liver stiffness was expressed in kiloPascal (kPa). Operators must have performed at least 50 procedures before participating in this study, and were blinded to all clinical data and the diagnoses of the patients. Since the number of participants with advanced fibrosis was low (16 out of 654 available data), subsequent analyses used the presence of possible advanced fibrosis as an outcome instead. The cut-off value of 7.9 kPa was used to estimate the number of subjects with possible advanced fibrosis according to a local validation study using liver histology as the reference standard \[[@pone.0122406.ref021]\].

Dietary assessment {#sec007}
------------------

Dietary intake was recorded using a modified version of a locally validated food-frequency questionnaire (FFQ) that captures food intake over 7 days \[[@pone.0122406.ref022]\] ([S1 File](#pone.0122406.s001){ref-type="supplementary-material"}). The questionnaire contained 297 food items in seven broad categories. To ensure data quality, the subjects filled in the questionnaires under the supervision of a trained research staff. Food replica, food containers, and a catalogue of pictures of individual food portions were provided to the subjects to assist portion size estimation. Daily nutrient intakes were estimated using Food Processor Nutrition analysis and Fitness software version 8.0 (ESHA Research, Salem, Oregon, USA) with the addition of local and Chinese food items \[[@pone.0122406.ref023]--[@pone.0122406.ref025]\]. All nutrient intakes were adjusted for dietary energy intake by the residual method for subsequent data analysis \[[@pone.0122406.ref026]\].

Estimation of dietary acid load {#sec008}
-------------------------------

Several algorithms have been developed to estimate acid load from diet \[[@pone.0122406.ref027]\]. Fassetto *et al*. calculated the estimated net endogenous acid production (NEAP) from the diet's protein to potassium ratio \[[@pone.0122406.ref028]\] whereas Remer *et al*. estimated diet-induced potential renal acid load (PRAL) from average intestinal absorption rates of ingested protein and other minerals as well as an anthropometry-based estimate for organic acid excretion \[[@pone.0122406.ref029]\]. Each has its rationale and limitations \[[@pone.0122406.ref030]\]. In this study, both markers of diet-induced acid load were calculated. Frassetto's method has been used in our previous study \[[@pone.0122406.ref031]\]. The method calculates the diet's protein/potassium ratio expressed as g/mEq. The rationale and algorithm of this method have been described previously and the estimated NEAP could account for about 70% of the variation in renal net acid excretion \[[@pone.0122406.ref028]\]. We also performed additional analyses using the PRAL as a second marker for diet-induced acid load, and the PRAL was calculated using an algorithm described by Remer *et al*. \[[@pone.0122406.ref027]\]:

PRAL (mEq/d) = 0.4888 × protein intake (g/d) + 0.0366 × phosphorus (mg/d)--0.0205 × potassium (mg/d) -- 0.0125 × calcium (mg/d) -- 0.0263 × magnesium (mg/d)

Both the estimated NEAP and the PRAL were energy-adjusted using residual method for subsequent analyses \[[@pone.0122406.ref026]\].

Statistical analysis {#sec009}
--------------------

Statistical tests were performed using the Statistical Package for Social Sciences version 21.0 (SPSS Inc., Chicago, US). Histograms were used to screen for normal distribution. Logarithmic transformation was applied to skewed variables whenever appropriate. Continuous variables were expressed in mean ± SD and compared using the independent *t* test if they were normally distributed. Skewed variables were expressed in median (IQR) and compared using the Mann-Whitney U test. Categorical variables were compared using chi-squared test or Fisher exact test as appropriate. Pearson's correlation or Spearman's rank correlation was used to examine the correlation between nutrient intakes or food group intakes and estimated NEAP or PRAL whenever appropriate.

Binary logistic regression models were applied to assess both the unadjusted and the adjusted associations between estimated NEAP or PRAL and the presence of NAFLD. Variables with *p* \<0.1 in the univariate analysis were entered into the multivariate analysis. The first multivariate model was adjusted for age, sex, BMI, being a current drinker, and the presence of metabolic syndrome. To avoid the multicollinearity problem, only the presence of metabolic syndrome was included in the multivariate regression model whereas WHR, WC, past history of hypertension, diabetes as well as hypercholesterolemia (all with *p* \<0.1 in univariate analysis) were not entered into the multivariate model. The second multivariate model was further adjusted for energy-adjusted dietary intakes of fiber, saturated fat, carbohydrates and protein as these nutrients were previously reported to be associated with NAFLD \[[@pone.0122406.ref032]\]. Similarly, the multicollinearity problem was checked and no significant multicollinearity problem was detected. Furthermore, we examined whether the association between estimated NEAP or PRAL and the presence of NAFLD varied according to sex and BMI (normal weight group \<23 vs. overweight and obese group [≥]{.ul}23 kg/m^2^). Interaction between sex or BMI status and estimated NEAP or PRAL was tested by addition of cross-product terms to the multivariate models. Interactions were not significant, thus all analyses are presented in the total population. To further check the possibility of reverse causation, a sensitivity analysis excluding 206 participants with medical history of hypertension, diabetes, hypercholesterolemia and ischemic heart disease was performed (n = 587). All models were adjusted for the same variables mentioned above.

Since NAFLD is benign in most of the cases, we further examined the association of the degree of liver fibrosis with estimated NEAP or PRAL. Binary logistic regression models were applied to assess both the unadjusted and the adjusted associations between estimated NEAP or PRAL and the presence of possible advanced fibrosis. Linear regression models were also used to examine both the unadjusted and the adjusted associations of estimated NEAP or PRAL with liver stiffness (as continuous variable). All models were adjusted for the same variables mentioned above. An α level of 5% was used as the level of significance.

Results {#sec010}
=======

There was no major difference in the baseline characteristics between the included subjects and the excluded subjects (data not shown). The mean [±]{.ul} SD age of 793 subjects was 48.1 [±]{.ul} 10.6 years (range 19--72 years), and 330 (41.6%) were male. All subjects were ethnic Chinese. 220 subjects were diagnosed with NAFLD and the prevalence of NAFLD was 27.7%. Subjects with NAFLD were older, and were likely to be male and current drinkers than subjects without NAFLD (all *p*\<0.05). They also had significantly higher BMI, higher WC, higher WHR, and higher percentage of hypertension, diabetes, hypercholesterolemia, and metabolic syndrome than those without NAFLD ([Table 1](#pone.0122406.t001){ref-type="table"}). Subjects with NAFLD tended to have a higher estimated NEAP or PRAL ([Table 2](#pone.0122406.t002){ref-type="table"}). Subjects with NAFLD and those without NAFLD showed similar nutrient intakes and food group intakes except for the intakes of milk and milk products, and meat, poultry and organ meat.

10.1371/journal.pone.0122406.t001

###### Baseline characteristics between subjects with and without NAFLD (n = 793).

![](pone.0122406.t001){#pone.0122406.t001g}

  Variables                                                                                                            No NAFLD (n = 573)              NAFLD (n = 220)               *P* [^1^](#t001fn001){ref-type="table-fn"}
  -------------------------------------------------------------------------------------------------------------------- -------------------- ---------- ----------------- ----------- --------------------------------------------
  Age (years)                                                                                                          47.0                 10.8       51.9              9.3         \<0.001
  BMI (kg/m^2^)                                                                                                        21.7                 3.0        25.5              3.5         \<0.001
  WHR                                                                                                                  0.84                 0.08       0.90              0.06        \<0.001
  WC (cm)                                                                                                              78.3                 9.2        89.2              7.6         \<0.001
  Male (%)                                                                                                                                  37.0                         53.6        \<0.001
  Current smoker (%)                                                                                                                        8.4                          8.6         0.906
  Current drinker (%)                                                                                                                       16.6                         25.0        0.007
  Hypertension (%)                                                                                                                          9.4                          31.8        \<0.001
  Diabetes (%)                                                                                                                              2.6                          8.2         \<0.001
  Hypercholesterolemia (%)                                                                                                                  10.2                         16.4        0.016
  Metabolic syndrome (%)                                                                                                                    7.9                          47.7        \<0.001
  ALT (IU/L)[^2^](#t001fn002){ref-type="table-fn"}                                                                     19                   15--25     31                23--42      \<0.001
  AST (IU/L)[^2^](#t001fn002){ref-type="table-fn"}                                                                     19                   17--22     22                18--27      \<0.001
  Intraheptic triglyceride content (%)[^2^](#t001fn002){ref-type="table-fn"}                                           1.2                  0.7--2.4   9.8               7.0--15.4   \<0.001
  Liver stiffness measurement (kPa)[^2^](#t001fn002){ref-type="table-fn"} ^,^ [^3^](#t001fn003){ref-type="table-fn"}   4.1                  3.5--4.9   4.6               4.0--5.7    \<0.001
  Liver stiffness (\> = 7.9 kPa)                                                                                                            3.8                          7.7         0.039

^1^ Group difference by independent t test or non-parametric Mann-Whitney U test for continuous variables and chi square or Fisher's exact test for categorical variables

^2^ Median and interquartile range

^3^ Included 654 subjects (182 with fatty liver and 472 without fatty liver) with valid transient elastography examination.

10.1371/journal.pone.0122406.t002

###### Dietary acid load and intakes of selected nutrients and food groups between subjects with and without NAFLD (n = 793).

![](pone.0122406.t002){#pone.0122406.t002g}

  Dietary variables                                                           No NAFLD (n = 573)                    NAFLD (n = 220)                    *P* [^1^](#t002fn001){ref-type="table-fn"}
  --------------------------------------------------------------------------- -------------------- ---------------- ----------------- ---------------- --------------------------------------------
  NEAP (mEq/d)                                                                                                                                         
    Raw                                                                       75.6                 20.6             78.5              22.6             0.080
    Energy adjusted                                                           75.2                 20.5             77.9              22.5             0.101
  PRAL (mEq/d)                                                                                                                                         
    Raw                                                                       23.0                 16.5             25.3              17.9             0.088
    Energy adjusted                                                           23.6                 14.2             25.7              16.1             0.072
  Energy intake (kcal/d)                                                      2066.1               610.2            2144.6            665.7            0.114
  \% energy from carbohydrates                                                50.5                 8.0              49.7              8.2              0.211
  \% energy from total fat                                                    32.6                 7.1              32.5              7.1              0.834
  \% energy from protein                                                      17.0                 3.4              17.4              3.5              0.171
  Carbohydrates (g/d)                                                         260.6                89.6             267.1             99.2             0.375
  Total fat (g/d)                                                             74.7                 27.2             77.2              27.8             0.242
  Saturated fat (g/d)                                                         17.1                 7.0              17.6              7.2              0.388
  Cholesterol (mg/d)                                                          289.3                133.6            305.0             138.6            0.142
  Protein (g/d)                                                               88.0                 32.8             92.5              33.5             0.085
  Fiber (g/d)[^2^](#t002fn002){ref-type="table-fn"}                           13.8                 10.5--18.3       14.2              9.8--18.4        0.778
  Potassium (mg/d)[^2^](#t002fn002){ref-type="table-fn"}                      2079.4               1652.4--2691.1   2134.4            1669.3--2736.3   0.627
  Vitamin C (mg/d)[^2^](#t002fn002){ref-type="table-fn"}                      105.5                69.6--160.8      103.0             62.9--161.3      0.282
  Calcium (mg/d)[^2^](#t002fn002){ref-type="table-fn"}                        508.4                397.6--681.6     530.6             389.6--693.1     0.781
  Magnesium (mg/d)                                                            280.2                101.2            292.2             111.6            0.148
  Phosphorus (mg/d)                                                           1111.7               386.5            1161.9            414.3            0.109
  Grains and cereals (g/d)[^2^](#t002fn002){ref-type="table-fn"}              521.4                395.7--685.7     556.4             414.3--740.0     0.079
  Fruits and dried fruits (g/d)[^2^](#t002fn002){ref-type="table-fn"}         175.0                103.6--272.9     165.5             100.0--271.1     0.633
  Vegetables and legumes (g/d)[^2^](#t002fn002){ref-type="table-fn"}          161.4                100.8--251.1     144.1             99.4--234.3      0.242
  Soy and soy products (g/d)[^2^](#t002fn002){ref-type="table-fn"}            34.3                 3.6--75.3        35.7              7.1--72.4        0.793
  Egg and egg products (g/d)[^2^](#t002fn002){ref-type="table-fn"}            14.3                 7.1--24.5        14.3              5.0--28.6        0.870
  Meat, poultry and organ meats (g/d)[^2^](#t002fn002){ref-type="table-fn"}   114.3                77.1--170.3      130.0             79.0--178.3      0.045
  Fish and seafood (g/d)[^2^](#t002fn002){ref-type="table-fn"}                60.7                 33.6--98.6       64.4              34.0--106.4      0.497
  Milk and milk products (g/d)[^2^](#t002fn002){ref-type="table-fn"}          14.3                 0.9--49.1        8.6               0.0--33.2        0.013

^1^ Group difference by independent t test or non-parametric Mann-Whitney U test

^2^ Median and interquartile range.

Estimated NEAP was positively associated with total protein intake, and was negatively associated with the intakes of vitamin C, fiber, and various alkaline producing minerals, such as magnesium and potassium (*p*\<0.05, [Table 3](#pone.0122406.t003){ref-type="table"}). With respect to specific food groups, higher estimated NEAP was associated with higher consumption of protein rich animal foods, and lower consumption of fruits, soy and soy products, and vegetables and legumes (*p*\<0.05, [Table 3](#pone.0122406.t003){ref-type="table"}). Similar correlations were observed when the analyses were performed using PRAL ([Table 3](#pone.0122406.t003){ref-type="table"}).

10.1371/journal.pone.0122406.t003

###### Correlation between estimated NEAP or PRAL and selected nutrients and food groups (n = 793).

![](pone.0122406.t003){#pone.0122406.t003g}

  Energy adjusted nutrients/food groups                                   Energy adjusted estimated NEAP (mEq/d)   Energy adjusted estimated PRAL (mEq/d)           
  ----------------------------------------------------------------------- ---------------------------------------- ---------------------------------------- ------- ---------
  Nutrients                                                                                                                                                         
    Total protein (g)                                                     0.28                                     \<0.001                                  0.57    \<0.001
    Vitamin C (mg)[^1^](#t003fn001){ref-type="table-fn"}                  -0.59                                    \<0.001                                  -0.46   \<0.001
    Calcium (mg)[^1^](#t003fn001){ref-type="table-fn"}                    -0.45                                    \<0.001                                  -0.27   \<0.001
    Phosphorus (mg)                                                       -0.09                                    0.010                                    0.25    \<0.001
    Fiber (g)[^1^](#t003fn001){ref-type="table-fn"}                       -0.67                                    \<0.001                                  -0.51   \<0.001
    Magnesium (mg)                                                        -0.46                                    \<0.001                                  -0.26   \<0.001
    Potassium (mg)[^1^](#t003fn001){ref-type="table-fn"}                  -0.65                                    \<0.001                                  -0.34   \<0.001
  Food groups (g)                                                                                                                                                   
    Grains and cereals[^1^](#t003fn001){ref-type="table-fn"}              0.01                                     0.835                                    0.05    0.134
    Egg and egg products[^1^](#t003fn001){ref-type="table-fn"}            0.15                                     \<0.001                                  0.18    \<0.001
    Fish and seafood[^1^](#t003fn001){ref-type="table-fn"}                -0.04                                    0.254                                    0.12    \<0.001
    Fruits and dried fruits[^1^](#t003fn001){ref-type="table-fn"}         -0.66                                    \<0.001                                  -0.54   \<0.001
    Meat, poultry and organ meats[^1^](#t003fn001){ref-type="table-fn"}   0.44                                     \<0.001                                  0.54    \<0.001
    Milk and milk products[^1^](#t003fn001){ref-type="table-fn"}          -0.09                                    0.011                                    -0.05   0.203
    Soy and soy products[^1^](#t003fn001){ref-type="table-fn"}            -0.13                                    \<0.001                                  -0.07   0.053
    Vegetables and legumes[^1^](#t003fn001){ref-type="table-fn"}          -0.46                                    \<0.001                                  -0.33   \<0.001

^1^ By Spearman's rank correlation.

[Table 4](#pone.0122406.t004){ref-type="table"} shows the results of logistic regression models linking energy adjusted estimated NEAP or PRAL and the likelihood of having NAFLD. The multivariate model adjusting for age, sex, BMI, current drinker status and the presence of metabolic syndrome suggested that a higher estimated NEAP was associated with an increased likelihood of having NAFLD. Further adjustment for dietary intakes of fiber, saturated fat, carbohydrates and protein did not change the results. Sensitivity analyses excluding participants with selected chronic diseases that could have affected their diets showed similar results (data not shown). However, such significant association was not observed when the regression analyses were performed using PRAL. Regarding the association between dietary acid load and the presence of possible advanced fibrosis, no significant association was detected in both unadjusted and adjusted models, regardless of markers for dietary acid load used. Analyses performed with liver stiffness as a continuous variable did not change the results (data not shown).

10.1371/journal.pone.0122406.t004

###### Logistic regression linking NEAP or PRAL and the presence of NAFLD (n = 793).

![](pone.0122406.t004){#pone.0122406.t004g}

  Models                                                        Energy adjusted estimated NEAP (mEq/d)   Energy adjusted estimated PRAL (mEq/d)                                 
  ------------------------------------------------------------- ---------------------------------------- ---------------------------------------- --------- ------ ------------ ---------
  Unadjusted (per 20 unit increase)                             1.13                                     0.96--1.32                               0.102     1.22   1.00--1.49   0.073
  Multivariate adjusted[^1^](#t004fn001){ref-type="table-fn"}                                                                                                                   
    NEAP (per 20 unit increase)                                 1.25                                     1.02--1.52                               0.022     ----                
    PRAL (per 20 unit increase)                                 ----                                                                                        1.15   0.87--1.51   0.341
    Sex                                                         1.64                                     1.08--2.48                               0.020     1.66   1.08--2.54   0.020
    Age (per 10 years increase)                                 1.31                                     1.06--1.63                               0.015     1.25   1.00--1.55   0.045
    BMI (kg/m^2^)                                               1.35                                     1.28--1.45                               \<0.001   1.35   1.27--1.44   \<0.001
    Current drinker                                             0.95                                     0.57--1.58                               0.835     0.92   0.56--1.53   0.758
    Metabolic syndrome                                          5.14                                     3.24--8.15                               \<0.001   5.12   3.23--8.12   \<0.001
  Multivariate adjusted[^2^](#t004fn002){ref-type="table-fn"}                                                                                                                   
    NEAP (per 20 unit increase)                                 1.32                                     1.01--1.74                               0.049     ----                
    PRAL (per 20 unit increase)                                 ----                                                                                        1.13   0.68--1.88   0.627
    Sex                                                         2.47                                     1.08--5.64                               0.032     2.62   1.15--5.98   0.022
    Age (per 10 years increase)                                 1.31                                     1.04--1.66                               0.018     1.27   1.02--1.58   0.033
    BMI (kg/m^2^)                                               1.36                                     1.27--1.45                               \<0.001   1.35   1.27--1.45   \<0.001
    Current drinker                                             0.92                                     0.54--1.55                               0.743     0.86   0.51--1.46   0.577
    Metabolic syndrome                                          5.19                                     3.26--8.25                               \<0.001   5.23   3.29--8.31   \<0.001
    Energy adjusted fiber intake (g/d)                          1.01                                     0.96--1.07                               0.734     0.99   0.93--1.05   0.640
    Energy adjusted saturated fat intake (g/d)                  0.98                                     0.92--1.04                               0.424     0.97   0.91--1.03   0.314
    Energy adjusted carbohydrates intake (g/d)                  1.00                                     0.99--1.00                               0.385     1.00   0.99--1.00   0.337
    Energy adjusted protein intake (g/d)                        0.99                                     0.98--1.00                               0.175     0.99   0.98--1.01   0.406

^1^ Variables with *p*\<0.1 in the univariate analysis were entered into the multivariate model

^2^ Further adjustment for energy-adjusted dietary intakes of fiber, saturated fat, carbohydrates and protein as these nutrients were previously reported to be associated with NAFLD \[[@pone.0122406.ref032]\].

Discussion {#sec011}
==========

Our data showed that higher estimated NEAP but not PRAL was associated with an increased likelihood of having NAFLD in Hong Kong Chinese adults, whereas both markers of dietary acid load were not associated with the presence of possible advance fibrosis.

To our knowledge, only one study has examined the association of dietary acid-base load and risk of NAFLD in a group of healthy Caucasian young men and women aged 18--25 years, and the study showed that higher dietary acidity as measured using the PRAL in adolescence may be prospectively associated with hepatic lipid accumulation in females \[[@pone.0122406.ref014]\]. However, one of the major limitations of this prospective study by Krupp *et al*. was the use of ALT, HSI, and FLI as surrogates of NAFLD. In our study, we used ^1^H-MRS, one of the most accurate non-invasive tests for measuring hepatic steatosis, and included data on fibrosis collected using transient elastography.

The potential link between estimated NEAP and NAFLD remains unclear. Accumulating evidence shows that reduced levels of GH and IGF-I in adults is associated with an increased prevalence of NAFLD and progression to NASH or liver cirrhosis \[[@pone.0122406.ref007]--[@pone.0122406.ref009]\]. Substantial evidence from animal studies and human studies also shows that metabolic acidosis suppresses GH secretion and IGF-I response \[[@pone.0122406.ref010], [@pone.0122406.ref011], [@pone.0122406.ref033]\]. In humans, Wiederkehr and colleagues reported that correction of renal acidosis by oral citrate administration to haemodialysis patients partly corrected IGF-1 levels and reversed GH insensitivity \[[@pone.0122406.ref011]\]. Therefore, it is postulated that high estimated NEAP may contribute to hepatic triglyceride accumulation possibly through its influence on the GH-IGF-I system. In contrast to the prospective study by Krupp's *et al*., we showed that higher estimated NEAP but not PRAL was modestly associated with NAFLD prevalence. Data on the association of estimated NEAP with NAFLD were not reported in Krupp's study, thus the association between different measures of dietary acid load and NAFLD remains uncertain. Differences in the outcome measures, the age range, as well as the dietary practice of the studied samples between our study and Krupp's study make the comparison of findings difficult. More studies are therefore needed to ascertain the link between dietary acid load and NAFLD.

Epidemiological data on the association between diet or nutrient composition and the development of NAFLD are limited. Previous studies on this aspect were mainly conducted in Caucasian populations and were seldom investigated among Chinese population. Existing evidence generally supports that a diet high in energy, simple carbohydrates, saturated fat, and cholesterol intakes but low in fiber content increases the risk of NAFLD \[[@pone.0122406.ref034], [@pone.0122406.ref035]\]. The relationship between protein intake and NAFLD risk is more complex. Dietary protein is part of the estimated NEAP or the PRAL and increasing protein intake increases dietary acidity. Therefore, a high protein intake could contribute to a GH resistance in the liver, through its influence on the acid-base balance. In contrast, an elevated IGF-I concentration has been reported in subjects with type 2 diabetes following a high-protein diet \[[@pone.0122406.ref036]\]. Experiments in rodents also showed that a high-protein and low-carbohydrate diet improved carbohydrate metabolism and decreased hepatic steatosis by inhibition of de novo lipogenesis \[[@pone.0122406.ref037], [@pone.0122406.ref038]\]. Therefore, we tried to further adjust for dietary fiber, saturated fat, carbohydrates and protein in our multivariate analysis and the association between estimated NEAP and the likelihood of prevalent NAFLD was slightly attenuated but remained significant, possibly suggesting that diet-induced acid load may constitute a nutritional factor with influence on NAFLD development. However, our findings were in line with other previous studies that metabolic syndrome is still the strongest factor associated with NAFLD \[[@pone.0122406.ref015], [@pone.0122406.ref039]\]. Therefore, the magnitude of effect of diet on NAFLD remains to be examined.

The strengths of our study include relatively large sample size, recruitment of subjects from the general population, and the use of ^1^H-MRS and transient elastography to assess hepatic steatosis and fibrosis respectively. However, our study has several limitations. First, our study was a cross-sectional study, thus the causal relationship between estimated NEAP and the likelihood of NAFLD cannot be determined. We tried to conduct a sensitivity analysis excluding participants with chronic diseases that could have affected their diets and similar results were observed. These results suggest that reverse causation seems an unlikely explanation for our findings. Second, the validated FFQ used in this study captured only the short term dietary and food intakes (i.e. the past week) of the participants. Perhaps longer-term dietary and food intakes are more valuable in examining the relationship between diet and risk of chronic diseases. Third, we did not have data on GH and IGF-I as well as biochemical markers regarding acid base load, such as serum anion gap and bicarbonate in the study, thus no evidence of the presence of low grade/mid metabolic acidosis in the subjects with NAFLD is available. The association of estimated NEAP as the underlying mechanism with NAFLD prevalence should therefore be regarded as speculation rather than conviction. Forth, the number of cases with possible advanced fibrosis may be insufficient to allow for an examination of the association between diet-induced acid load and the presence of possible advanced fibrosis. Besides, although we controlled for various common factors and major medical conditions in the analysis, residual potential confounding from some other important factors related to the development of NAFLD, such as physical activity level might still be present.

In conclusion, our findings suggest that there may be a modest association between diet-induced acid load and NAFLD. More studies are needed to ascertain the link between diet-induced acid load and NAFLD and to investigate the underlying mechanisms.
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